Micro-RNA: The darkhorse of cancer

Lee, 1993, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell, 75, 843, 10.1016/0092-8674(93)90529-Y Reinhart, 2000, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans, Nature, 403, 901, 10.1038/35002607 Peng, 2016, The role of MicroRNAs in human cancer, Sig. Transduc.Targeted Ther., 1, 1 Wahid, 2010, MicroRNAs: synthesis, mechanism, function, and recent clinical trials, Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1803, 1231, 10.1016/j.bbamcr.2010.06.013 MacFarlane, 2010, MicroRNA: biogenesis, function and role in cancer, Current genomics, 11, 537, 10.2174/138920210793175895 Hayashita, 2005, A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation, Cancer Res., 65, 9628, 10.1158/0008-5472.CAN-05-2352 Aziz, 2020, MicroRNAs in ovarian cancer and recent advances in the development of microRNA-based biosensors, Analyst, 145, 2038, 10.1039/C9AN02263E Thomson, 2004, A custom microarray platform for analysis of microRNA gene expression, Nat. Methods, 1, 47, 10.1038/nmeth704 Zhang, 2007, microRNAs as oncogenes and tumor suppressors, Dev. Biol., 302, 1, 10.1016/j.ydbio.2006.08.028 Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702 Schmittgen, 2004, A high-throughput method to monitor the expression of microRNA precursors, Nucleic Acids Res., 32, e43, 10.1093/nar/gnh040 Fiedler, 2010, Quantitative RT-PCR methods for mature microRNA expression analysis, Methods Mol. Biol., 630, 49, 10.1007/978-1-60761-629-0_4 He, 2019, Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer, J. Clin. Lab. Anal., 33, 10.1002/jcla.23003 Gan, 2013, Profiling pre-microRNA and mature microRNA expressions using a single microarray and avoiding separate sample preparation, Microarrays (Basel, Switzerland), 2, 24 Waggott, 2012, Nano string norm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data, Bioinformatics, 28, 1546, 10.1093/bioinformatics/bts188 Tsang, 2017, NanoString, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics, Expert. Rev. Mol. Diagn., 17, 95, 10.1080/14737159.2017.1268533 Eastel, 2019, Application of NanoString technologies in companion diagnostic development, Expert. Rev. Mol. Diagn., 19, 591, 10.1080/14737159.2019.1623672 Valera, 2020, microRNA expression profiling in young prostate cancer patients, J. Cancer, 11, 4106, 10.7150/jca.37842 Reis, 2020, Circulating miR-16-5p, miR-92a-3p, and miR-451a in plasma from lung cancer patients: potential application in early detection and a regulatory role in tumorigenesis pathways, Cancers, 12, 2071, 10.3390/cancers12082071 Coenen-Stass, 2018, Evaluation of methodologies for microRNA biomarker detection by next generation sequencing, RNA Biol., 15, 1133 Bisgin, 2018, Evaluation of bioinformatics approaches for next-generation sequencing analysis of microRNAs with a toxicogenomics study design, Front. Genet., 9, 22, 10.3389/fgene.2018.00022 Motameny, 2010, Next generation sequencing of miRNAs–strategies, resources and methods, Genes, 1, 70, 10.3390/genes1010070 LeBlanc, 2015, Next-generation sequencing approaches in cancer: where have they brought us and where will they take us?, Cancers, 7, 1925, 10.3390/cancers7030869 Matullo, 2016, Micro RNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids, Int. J. Cancer, 138, 2334, 10.1002/ijc.29895 Reinhart, 2000, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans, Nature, 403, 901, 10.1038/35002607 Pasquinelli, 2000, Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA, Nature, 408, 86, 10.1038/35040556 Michlewski, 2008, Posttranscriptional regulation of miRNAs harboring conserved terminal loops, Mol. Cell, 32, 383, 10.1016/j.molcel.2008.10.013 Viswanathan, 2010, Lin28: A microRNA regulator with a macro role, Cell, 140, 445, 10.1016/j.cell.2010.02.007 Han, 2007, DNA methylation regulates MicroRNA expression, Cancer Biol. & Ther., 6, 1290, 10.4161/cbt.6.8.4486 Calin, 2004, Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers, Proc. Natl. Acad. Sci., 101, 2999, 10.1073/pnas.0307323101 Zhang, 2006, microRNAs exhibit high frequency genomic alterations in human cancer, Proc. Natl. Acad. Sci., 103, 9136, 10.1073/pnas.0508889103 Cimmino, 2005, miR-15 and miR-16 induce apoptosis by targeting BCL2, Proc. Natl. Acad. Sci., 102, 13944, 10.1073/pnas.0506654102 Calin, 2002, Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia, Proc. Natl. Acad. Sci., 99, 15524, 10.1073/pnas.242606799 Kotani, 2010, A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells, Cell Cycle, 9, 1037, 10.4161/cc.9.6.11011 O’Donnell, 2005, c-Myc-regulated microRNAs modulate E2F1 expression, Nature, 435, 839, 10.1038/nature03677 Dews, 2006, Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster, Nat. Genet., 38, 1060, 10.1038/ng1855 Bracken, 2008, A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition, Cancer Res., 68, 7846, 10.1158/0008-5472.CAN-08-1942 Lee, 2002, MicroRNA maturation: stepwise processing and subcellular localization, EMBO J., 21, 4663, 10.1093/emboj/cdf476 Zeng, 2003, Sequence requirements for micro RNA processing and function in human cells, RNA, 9, 112, 10.1261/rna.2780503 Lee, 2003, The nuclear RNase III Drosha initiates microRNA processing, Nature, 425, 415, 10.1038/nature01957 Han, 2004, The Drosha-DGCR8 complex in primary microRNA processing, Genes Dev., 18, 3016, 10.1101/gad.1262504 Denli, 2004, Processing of primary microRNAs by the microprocessor complex, Nature, 432, 231, 10.1038/nature03049 Gregory, 2004, The microprocessor complex mediates the genesis of microRNAs, Nature, 432, 235, 10.1038/nature03120 Landthaler, 2004, The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis, Curr. Biol., 14, 2162, 10.1016/j.cub.2004.11.001 Han, 2006, Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex, Cell, 125, 887, 10.1016/j.cell.2006.03.043 Zeng, 2005, Efficient processing of primary microRNA hairpins by Drosha requires flanking nonstructured RNA sequences, J. Biol. Chem., 280, 27595, 10.1074/jbc.M504714200 Du, 2005, microPrimer: the biogenesis and function of microRNA, Development, 132, 4645, 10.1242/dev.02070 Muralidhar, 2011, Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles, J. Pathol., 224, 496, 10.1002/path.2898 Muralidhar, 2007, Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels, J. Pathol. A J. Pathol. Soc. Great Britain and Ireland, 212, 368 Sugito, 2006, RNASEN regulates cell proliferation and affects survival in esophageal cancer patients, Clin. Cancer Res., 12, 7322, 10.1158/1078-0432.CCR-06-0515 Papachristou, 2012, Immunohistochemical analysis of the endoribonucleases Drosha, Dicer and Ago2 in smooth muscle tumours of soft tissues, Histopathology, 60, E28, 10.1111/j.1365-2559.2012.04192.x Lin, 2010, microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma, Cancer Res., 70, 7841, 10.1158/0008-5472.CAN-10-0970 Shu, 2012, Expression of CDC6 and GDF-9 and their clinicopathological significances in benign and malignant lesions of the gallbladder, Cancer Biomarkers, 11, 107, 10.3233/CBM-2012-0267 Lin, 2015, MicroRNA biogenesis pathways in cancer, Nat. Rev. Cancer, 15, 321, 10.1038/nrc3932 Grund, 2012, Rare Drosha splice variants are deficient in microRNA processing but do not affect general microRNA expression in cancer cells, Neoplasia (New York, NY), 14, 238, 10.1593/neo.111586 Tchernitsa, 2010, Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression, J. Pathol., 222, 310, 10.1002/path.2759 Vaksman, 2012, Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma, Hum. Pathol., 43, 2062, 10.1016/j.humpath.2012.02.016 Catto, 2009, Distinct microRNA alterations characterize high-and low-grade bladder cancer, Cancer Res., 69, 8472, 10.1158/0008-5472.CAN-09-0744 Yan, 2012, Dysregulated expression of dicer and drosha in breast cancer, Pathol. Oncol. Res., 18, 343, 10.1007/s12253-011-9450-3 Sand, 2012, Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer, Mol. Carcinog., 51, 916, 10.1002/mc.20861 Ambs, 2008, Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer, Cancer Res., 68, 6162, 10.1158/0008-5472.CAN-08-0144 Kim, 2014, An essential microRNA maturing microprocessor complex component DGCR8 is up-regulated in colorectal carcinomas, Clin. Exp. Med., 14, 331, 10.1007/s10238-013-0243-8 Guo, 2015, Silencing the double-stranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion, Pharm. Res., 32, 769, 10.1007/s11095-013-1219-9 Torres, 2011, Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer, Tumor Biol., 32, 769, 10.1007/s13277-011-0179-0 Zhu, 2012, Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia, Cancer Sci., 103, 875, 10.1111/j.1349-7006.2012.02234.x Wang, 2011, Dynamic mechanisms for pre-miRNA binding and export by Exportin-5, Rna, 17, 1511, 10.1261/rna.2732611 Wu, 2018, The role of exportin-5 in microRNA biogenesis and cancer, Genomics, Proteomics & Bioinform., 16, 120, 10.1016/j.gpb.2017.09.004 Melo, 2010, A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells, Cancer Cell, 18, 303, 10.1016/j.ccr.2010.09.007 Leaderer, 2011, Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis, Int. J. Mol. Epidemiol.Genet., 2, 9 Sun, 2016, ERK activation globally downregulates miRNAs through phosphorylating exportin-5, Cancer Cell, 30, 723, 10.1016/j.ccell.2016.10.001 Ali Syeda, 2020, Regulatory mechanism of microrna expression in cancer, Int. J. Mol. Sci., 21, 1723, 10.3390/ijms21051723 Zhang, 2002, Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP, EMBO J., 21, 5875, 10.1093/emboj/cdf582 Provost, 2002, Ribonuclease activity and RNA binding of recombinant human Dicer, EMBO J., 21, 5864, 10.1093/emboj/cdf578 Saito, 2005, Processing of pre-microRNAs by the Dicer-1–Loquacious complex in Drosophila cells, PLoS Biol., 3, l30, 10.1371/journal.pbio.0030235 Chendrimada, 2005, TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing, Nature, 436, 740, 10.1038/nature03868 Tomari, 2004, A protein sensor for siRNA asymmetry, Science, 306, 1377, 10.1126/science.1102755 Diederichs, 2007, Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression, Cell, 131, 1097, 10.1016/j.cell.2007.10.032 Robb, 2007, RNA helicase A interacts with RISC in human cells and functions in RISC loading, Mol. Cell, 26, 523, 10.1016/j.molcel.2007.04.016 Lee, 1992, A new RNA helicase isolated from HeLa cells that catalytically translocates in the 3’to 5’direction, J. Biol. Chem., 267, 4398, 10.1016/S0021-9258(18)42849-9 Friedemann, 2005, Nuclear DNA helicase II (RNA helicase A) interacts with Werner syndrome helicase and stimulates its exonuclease activity, J. Biol. Chem., 280, 31303, 10.1074/jbc.M503882200 Kumar, 2007, Impaired microRNA processing enhances cellular transformation and tumorigenesis, Nat. Genet., 39, 673, 10.1038/ng2003 Kumar, 2009, Dicer1 functions as a haploinsufficient tumor suppressor, Genes Dev., 23, 2700, 10.1101/gad.1848209 Kim, 2014, An essential microRNA maturing microprocessor complex component DGCR8 is up-regulated in colorectal carcinomas, Clin. Exp. Med., 14, 331, 10.1007/s10238-013-0243-8 Hill, 2009, DICER1 mutations in familial pleuropulmonary blastoma, Science, 325, 965, 10.1126/science.1174334 Heravi-Moussavi, 2012, Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers, New England J. Med., 366, 234, 10.1056/NEJMoa1102903 Anglesio, 2013, Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage, J. Pathol., 229, 400, 10.1002/path.4135 Slade, 2011, DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome, J. Med. Genet., 48, 273, 10.1136/jmg.2010.083790 Zhu, 2012, Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia, Cancer Sci., 103, 875, 10.1111/j.1349-7006.2012.02234.x Lee, 2009, MicroRNAs in cancer, Ann. Rev. Pathol.: Mech. Dis., 4, 199, 10.1146/annurev.pathol.4.110807.092222 Liu, 2005, MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies, Nat. Cell Biol., 7, 719, 10.1038/ncb1274 Chu, 2006, Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54, PLoS Biol., 4, 10.1371/journal.pbio.0040210 Grimson, 2007, MicroRNA targeting specificity in mammals: determinants beyond seed pairing, Mol. Cell, 27, 91, 10.1016/j.molcel.2007.06.017 Behm-Ansmant, 2006, mRNA degradation by miRNAs and GW182 requires both CCR4: NOT deadenylase and DCP1: DCP2 decapping complexes, Genes Dev., 20, 1885, 10.1101/gad.1424106 Gantier, 2007, Fine-tuning of the innate immune response by microRNAs, Immunol. Cell Biol., 85, 458, 10.1038/sj.icb.7100091 Garzon, 2009, MicroRNAs in cancer, Annu. Rev. Med., 60, 167, 10.1146/annurev.med.59.053006.104707 Sullivan, 2005, MicroRNAs and viral infection, Mol. Cell, 20, 3, 10.1016/j.molcel.2005.09.012 Poy, 2004, A pancreatic islet-specific microRNA regulates insulin secretion, Nature, 432, 226, 10.1038/nature03076 Chang, 2004, MicroRNAs act sequentially and asymmetrically to control chemosensory laterality in the nematode, Nature, 430, 785, 10.1038/nature02752 Fazi, 2005, A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis, Cell, 123, 819, 10.1016/j.cell.2005.09.023 Yekta, 2004, MicroRNA-directed cleavage of HOXB8 mRNA, Science, 304, 594, 10.1126/science.1097434 Michael, 2003, Reduced Accumulation of Specific MicroRNAs in Colorectal Neoplasia11Note: Susan M. O'Connor and Nicholas G. van Holst Pellekaan contributed equally to this work, Mol. Cancer Res., 1, 882 He, 2005, A microRNA polycistron as a potential human oncogene, Nature, 435, 828, 10.1038/nature03552 Jing, 2005, Involvement of microRNA in AU-rich element-mediated mRNA instability, Cell, 120, 623, 10.1016/j.cell.2004.12.038 Xu, 2003, The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism, Curr. Biol., 13, 790, 10.1016/S0960-9822(03)00250-1 Slack, 2000, The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor, Mol. Cell, 5, 659, 10.1016/S1097-2765(00)80245-2 Abrahante, 2003, The Caenorhabditis elegans hunchback-like gene lin-57/hbl-1 controls developmental time and is regulated by microRNAs, Dev. Cell, 4, 625, 10.1016/S1534-5807(03)00127-8 Jansson, 2012, MicroRNA and cancer, Mol. Oncol., 6, 590, 10.1016/j.molonc.2012.09.006 Si, 2007, miR-21-mediated tumor growth, Oncogene, 26, 2799, 10.1038/sj.onc.1210083 Iorio, 2005, MicroRNA gene expression deregulation in human breast cancer, Cancer Res., 65, 7065, 10.1158/0008-5472.CAN-05-1783 Kong, 2012, microRNAs in cancer management, Llancet Oncol., 13, e249, 10.1016/S1470-2045(12)70073-6 Lee, 2007, MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression, Proc. Natl. Acad. Sci., 104, 20350, 10.1073/pnas.0706901104 Reddy, 2015, MicroRNA (miRNA) in cancer, Cancer Cell Int., 15, 38, 10.1186/s12935-015-0185-1 Lagana, 2010, Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material, PLoS One, 5, 10.1371/journal.pone.0011166 Mayr, 2007, Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation, Science, 315, 1576, 10.1126/science.1137999 Mishra, 2008, MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics, Cell Cycle, 7, 853, 10.4161/cc.7.7.5666 Lopez-Serra, 2012, DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer, Oncogene, 31, 1609, 10.1038/onc.2011.354 Saito, 2006, Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells, Cancer Cell, 9, 435, 10.1016/j.ccr.2006.04.020 Lehmann, 2008, Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer, J. Pathol., 214, 17, 10.1002/path.2251 Toyota, 2008, Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer, Cancer Res., 68, 4123, 10.1158/0008-5472.CAN-08-0325 Lujambio, 2007, Genetic unmasking of an epigenetically silenced microRNA in human cancer cells, Cancer Res., 67, 1424, 10.1158/0008-5472.CAN-06-4218 Brueckner, 2007, The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function, Cancer Res., 67, 1419, 10.1158/0008-5472.CAN-06-4074 Scott, 2006, Rapid alteration of microRNA levels by histone deacetylase inhibition, Cancer Res., 66, 1277, 10.1158/0008-5472.CAN-05-3632 Fabbri, 2007, MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B, Proc. Natl. Acad. Sci., 104, 15805, 10.1073/pnas.0707628104 Varambally, 2008, Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer, Science, 322, 1695, 10.1126/science.1165395 Ma, 2007, Tumour invasion and metastasis initiated by microRNA-10b in breast cancer, Nature, 449, 682, 10.1038/nature06174 Bommer, 2007, p53-mediated activation of miRNA34 candidate tumor-suppressor genes, Curr. Biol., 17, 1298, 10.1016/j.cub.2007.06.068 Tarasov, 2007, Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest, Cell Cycle, 6, 1586, 10.4161/cc.6.13.4436 He, 2007, A microRNA component of the p53 tumour suppressor network, Nature, 447, 1130, 10.1038/nature05939 Kent, 2006, A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes, Oncogene, 25, 6188, 10.1038/sj.onc.1209913 He, 2005, The role of microRNA genes in papillary thyroid carcinoma, Proc. Natl. Acad. Sci., 102, 19075, 10.1073/pnas.0509603102 Ota, 2004, Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma, Cancer Res., 64, 3087, 10.1158/0008-5472.CAN-03-3773 Volinia, 2006, A microRNA expression signature of human solid tumors defines cancer gene targets, Proc. Natl. Acad. Sci., 103, 2257, 10.1073/pnas.0510565103 Tagawa, 2007, Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development, Cancer Sci., 98, 1482, 10.1111/j.1349-7006.2007.00531.x Tagawa, 2005, A microRNA cluster as a target of genomic amplification in malignant lymphoma, Leukemia, 19, 2013, 10.1038/sj.leu.2403942 Schulte, 2008, MYCN regulates oncogenic MicroRNAs in neuroblastoma, Int. J. Cancer, 122, 699, 10.1002/ijc.23153 Sylvestre, 2007, An E2F/miR-20a autoregulatory feedback loop, J. Biol. Chem., 282, 2135, 10.1074/jbc.M608939200 Woods, 2007, Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors, J. Biol. Chem., 282, 2130, 10.1074/jbc.C600252200 Bos, 1989, Ras oncogenes in human cancer: a review, Cancer Res., 49, 4682 Johnson, 2005, RAS is regulated by the let-7 microRNA family, Cell, 120, 635, 10.1016/j.cell.2005.01.014 Reeves, 2001, Molecular biology of HMGA proteins: hubs of nuclear function, Gene, 277, 63, 10.1016/S0378-1119(01)00689-8 Wang, 2007, A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas, Genes Chromosom. Cancer, 46, 336, 10.1002/gcc.20415 Jiang, 2004, Wang X. Cytochrome-c-mediated apoptosis, Annu. Rev. Biochem., 73, 87, 10.1146/annurev.biochem.73.011303.073706 Cory, 2003, The Bcl-2 family: roles in cell survival and oncogenesis, Oncogene, 22, 8590, 10.1038/sj.onc.1207102 Tam, 1997, Mol. Cell. Biol., 17, 1490, 10.1128/MCB.17.3.1490 Tam, 2002, Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis, J. Virol., 76, 4275, 10.1128/JVI.76.9.4275-4286.2002 Eis, 2005, Accumulation of miR-155 and BIC RNA in human B cell lymphomas, Proc. Natl. Acad. Sci., 102, 3627, 10.1073/pnas.0500613102 Costinean, 2006, Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice, Proc. Natl. Acad. Sci., 103, 7024, 10.1073/pnas.0602266103 Chan, 2005, MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells, Cancer Res., 65, 6029, 10.1158/0008-5472.CAN-05-0137 Qi, 2009, Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma, BMC Cancer, 9, 163, 10.1186/1471-2407-9-163 Meng, 2007, MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer, Gastroenterology, 133, 647, 10.1053/j.gastro.2007.05.022 Kim, 2006, Tumours and tremors: how PTEN regulation underlies both, Br. J. Cancer, 94, 620, 10.1038/sj.bjc.6602994 Iijima, 2002, Tumor suppressor PTEN mediates sensing of chemoattractant gradients, Cell, 109, 599, 10.1016/S0092-8674(02)00745-6 Zhu, 2008, MicroRNA-21 targets tumor suppressor genes in invasion and metastasis, Cell Res., 18, 350, 10.1038/cr.2008.24 Park, 2002, PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation, Cancer Res., 62, 6318 Zhu, 2007, MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1), J. Biol. Chem., 282, 14328, 10.1074/jbc.M611393200 Serrano, 1997, Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a, Cell, 88, 593, 10.1016/S0092-8674(00)81902-9 Voorhoeve, 2006, A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors, Cell, 124, 1169, 10.1016/j.cell.2006.02.037 El-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817, 10.1016/0092-8674(93)90500-P Li, 2003, A global transcriptional regulatory role for c-Myc in Burkitt’s lymphoma cells, Proc. Natl. Acad. Sci., 100, 8164, 10.1073/pnas.1332764100 Song, 2019, Role of miR-221/222 in Tumor Development and the Underlying Mechanism, J. Oncol., 2, 7252013 Callegari, 2012, Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model, Hepatology, 56, 1025, 10.1002/hep.25747 Mertens-Talcott, 2007, The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells, Cancer Res., 67, 11001, 10.1158/0008-5472.CAN-07-2416 Samols, 2007, Identification of cellular genes targeted by KSHV-encoded microRNAs, PLoS Pathog., 3, 10.1371/journal.ppat.0030065 Chang, 2007, Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis, Mol. Cell, 26, 745, 10.1016/j.molcel.2007.05.010 Galardi, 2007, miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1, J. Biol. Chem., 282, 23716, 10.1074/jbc.M701805200 Kasinski, 2011, MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy, Nat. Rev. Cancer, 11, 849, 10.1038/nrc3166 Maddalena, 2015, MicroRNAs used in combination with anti-cancer treatments can enhance therapy efficacy, Mini-Rev. Med. Chem., 15, 1052, 10.2174/1389557515666150709115355 Zhu, 2012, miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP, Cancer Chemother. Pharmacol., 69, 723, 10.1007/s00280-011-1752-3 Jeon, 2011, ID4 imparts chemoresistance and cancer stemness to glioma cells by depressing miR-9*–mediated suppression of SOX2, Cancer Res., 71, 3410, 10.1158/0008-5472.CAN-10-3340 Ye, 2018, Differential microRNA expression profiles in tamoxifen-resistant human breast cancer cell lines induced by two methods, Oncol. Lett., 15, 3532 Cittelly, 2010, Downregulation of miR-342 is associated with tamoxifen resistant breast tumors, Mol. Cancer, 9, 317, 10.1186/1476-4598-9-317 Miller, 2008, MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1, J. Biol. Chem., 283, 29897, 10.1074/jbc.M804612200 Zhu, 2019, MicroRNA-506-3p reverses gefitinib resistance in non-small cell lung cancer by targeting Yes-associated protein 1, Mol. Med. Rep., 19, 1331 Zhong, 2010, MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer, Chem. Biol. Interact., 184, 431, 10.1016/j.cbi.2010.01.025 Ge, 2019, miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer, BMC Cancer, 19, 1203, 10.1186/s12885-019-6416-4 Liu, 2020, MiR-450a-5p strengthens the drug sensitivity of gefitinib in glioma chemotherapy via regulating autophagy by targeting EGFR, Oncogene, 39, 6190, 10.1038/s41388-020-01422-9 Azuma, 2020, Cancer exosomal microRNAs from gefitinib-resistant lung cancer cells cause therapeutic resistance in gefitinib-sensitive cells, Surg. Today, 50, 1099, 10.1007/s00595-020-01976-x Ashrafizadeh, 2020, MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer, Life Sci., 117973 Han, 2020, Plasma exosomal miRNA expression profile as oxaliplatin-based chemoresistant biomarkers in colorectal adenocarcinoma, Front. Oncol., 10, 1495, 10.3389/fonc.2020.01495 Lim, 2020, Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer, Oncogenesis, 9, 91, 10.1038/s41389-020-00275-x Marjaneh, 2018, The role of microRNAs in 5-FU resistance of colorectal cancer: Possible mechanisms, J. Cell. Physiol., 234, 2306, 10.1002/jcp.27221 Xu, 2020, MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer, Cancer Sci., 111, 1528, 10.1111/cas.14356 Holleman, 2011, miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo, Oncogene, 30, 4386, 10.1038/onc.2011.148 Cochrane, 2009, MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents, Mol. Cancer Ther., 8, 1055, 10.1158/1535-7163.MCT-08-1046 Wu, 2013, Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel, Cancer Chemother. Pharmacol., 71, 1159, 10.1007/s00280-013-2108-y Chen, 2020, Exploring specific miRNA-mRNA axes with relationship to taxanes-resistance in breast cancer, Front. Oncol., 10, 1397, 10.3389/fonc.2020.01397 Hassan, 2021, Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer, Sci. Rep., 11, 562, 10.1038/s41598-020-78596-5 O’brien, 2018, Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379, Oncogene, 37, 2137, 10.1038/s41388-017-0116-9 O'Neill, 2020, Nanoparticle-based delivery of tumor suppressor microRNA for cancer therapy, Cells, 9, 521, 10.3390/cells9020521 Moro, 2019, Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models, J. Control. Release, 308, 44, 10.1016/j.jconrel.2019.07.006 Gokita, 2020, Therapeutic potential of lnp-mediated delivery of miR-634 for cancer therapy, Mol. Therapy-Nucleic Acids, 19, 330, 10.1016/j.omtn.2019.10.045 Sukumar, 2019, Intranasal delivery of targeted polyfunctional gold–iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide, Biomaterials, 218, 119342, 10.1016/j.biomaterials.2019.119342 Oshima, 2017, In vivo delivery and therapeutic effects of a microRNA on colorectal liver metastases, Mol. Ther., 25, 1588, 10.1016/j.ymthe.2017.04.005 Weber, 2010, The microRNA spectrum in 12 body fluids, Clin. Chem., 56, 1733, 10.1373/clinchem.2010.147405 Wang, 2009, Circulating microRNAs, potential biomarkers for drug-induced liver injury, Proc. Natl. Acad. Sci., 106, 4402, 10.1073/pnas.0813371106 Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat. Cell Biol., 9, 654, 10.1038/ncb1596 Arroyo, 2011, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proc. Natl. Acad. Sci., 108, 5003, 10.1073/pnas.1019055108